cro.directory
← Compare landing

Confluence Discovery Technologies, Inc. vs Cyagen Biosciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/confluencediscovery/cyagen

CategoryConfluence Discovery Technologies, Inc.Cyagen Biosciences
Listed sitecrocro
SummaryFull-service drug discovery CRO specializing in cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, and in vivo efficacy models from idea through IND.Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.
Services
  • Discovery Research
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vivo Efficacy Models
  • Biomarker Assays
  • Immunology & Inflammation Services
  • Translational Research
  • Specialized & Large-Animal Models
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Translational Research
  • Immunology & Inflammation Services
  • Virology Services
ModalitiesData not yet provided.
  • Biologics (Monoclonal Antibodies)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Ophthalmology
LocationsData not yet provided.
  • Headquarters, Santa Clara, California, United States
CertificationsData not yet provided.
  • AAALAC International · Identifier: AAALAC-accredited facilities
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.